Searched for
VOLUNTARY LICENSING AGREEMENT
India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...- AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...
- Experts flag UK-India FTA over patent terms, access to drugsConcerns are mounting in India over the UK-India Free Trade Agreement's potential impact on access to affordable medicines. Experts fear th...
- India-UK trade pact subtly curtails India's ability to issue compulsory licenses: GTRIIndia's free trade agreement with the UK includes clauses on intellectual property. These clauses may limit India's ability to issue compul...
- Aurobindo to produce, supply long acting HIV treatment drugAurobindo Pharma will manufacture and supply long-acting injectable HIV treatment, cabotegravir, across 133 countries through a voluntary l...
- Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drugIndia's Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Me...
- Pfizer enters deal with UN-backed MPP to license COVID drug in 95 countries including IndiaPfizer said it will waive royalties on sales in all countries covered by the agreement while COVID-19 remains classified as a Public Health...
- Pfizer to allow generic versions of its COVID-19 pill in 95 countriesThe voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified ...
- MSD enters pact with UN-backed MPP to license COVID drug molnupiravir in 105 countries including IndiaUnder the terms of the agreement, MPP will be permitted to further license non-exclusive sub-licences to manufacturers and diversify the ma...
- Bajaj Healthcare moves Indian patent office for compulsory licence for Covid drugEli Lilly & Company declined the applications on both the occasion, citing the reason that it is really challenging for them to sign volunt...
- BDR Pharma inks licensing pact with Eli Lilly for COVID-19 treatment drugBaricitinib has received restricted emergency use approval, for use in combination with Remdesivir, for treatment of suspected or laborator...
- Eli Lilly inks pacts for COVID-19 drug Baricitinib with Torrent Pharma, Dr Reddy's, MSN LabsThe company has issued additional royalty-free, non-exclusive voluntary licences to Dr Reddy's, MSN Laboratories and Torrent Pharmaceutical...
- Dr Reddy's inks licensing pact with Eli Lilly for COVID-19 treatment drugThe Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company fo...
- MSD in talks with Medicines Patent Pool for additional licenses for molnupiravirMSD entered into a voluntary licensing agreement with five Indian drug makers including Sun Pharma, Cipla, Dr. Reddy’s, Emcure and Hetero f...
- MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufactur...
- India cites global shortage of Covid-19 vaccines as consensus eludes its TRIPS waiver proposalNew Delhi termed developed countries’ argument on the sufficiency of such licensing arrangements for ramping up manufacturing capacities “w...
- Large pharma companies back appeal for TRIPS waiver for Covid-19 cure“We endorse the Indian government’s stand asking for a waiver of the TRIPS provisions to deal with the Covid-19 crisis. This is the time fo...
- These are the companies manufacturing COVID-19 drug Remdesivir in India
- BDR Pharmaceuticals move on Remdesivir clone irks GileadThe Indian company had submitted its application for manufacturing the Covid-19 drug to the Drug Controller General of India (DCGI) last we...
- Covid-19 treatment: Cipla, Hetero Lab get nod to manufacture and sell RemdesivirCipla, Hetero, and Jubilant Lifesciences have signed voluntary licensing agreements with Gilead.
Load More
